(주)한국비티비

Unveiling 'Hexa' HIFU Technology with Dynamic Zoom Laser and Advanced Drug Delivery Capabilities

BTB Korea has launched a global market offensive by unveiling three new proprietary medical devices. The new lineup includes the world's first 1726nm fractional laser, a HIFU-based drug delivery platform, and a homecare device, signaling a major move to demonstrate its technological competitiveness in the dermatology and medical device markets.

BTB Korea announced on the 13th that it first showcased the three new products at 'KIMES 2026', Korea's largest medical device exhibition, held from March 19 to 22. The company is simultaneously pursuing domestic and international regulatory approvals, targeting sequential launches between the end of the second quarter and the third quarter of this year.

The flagship product unveiled is the 1726nm fractional laser. Equipped with a proprietary 'Dynamic Zoom' feature, it allows real-time adjustment of the spot size, enabling precise control of lesions based on treatment area and depth. Furthermore, it incorporates an artificial intelligence (AI)-based mechanism that automatically optimizes laser pulse shapes and widths, expanding precision and applicability compared to conventional fractional lasers.

The second product is a platform utilizing 'Hexa' spatio-temporally dispersed HIFU technology. By rapidly dispersing focal points in space and time, it precisely treats broad three-dimensional areas, offering not only non-invasive lifting but also drug delivery capabilities. Notably, it presents the potential to deliver therapeutic agents, such as anti-cancer drugs, to deep tissues including the blood-brain barrier (BBB), raising expectations for its expansion into various medical fields such as inflammation, pain, and cancer treatment support.

The third product is a homecare device that scales down clinical-grade technology for home use. This is part of a two-track strategy combining B2C with the existing B2B-focused business structure, aimed at driving top-line growth by broadening touchpoints in the consumer market.

Alongside the new product launches, BTB Korea is expanding its recruitment of core talent to strengthen its R&D, sales, and marketing organizations. Additionally, the company plans to pursue a stock reverse split (stock consolidation) to enhance stock price stability and corporate value.